Community/Retail

Simon Lu, pharmacy student at Rutgers University's Ernest Mario School of Pharmacy, talks about the importance of developing relationships with patients.

Allergan, a leading global pharmaceutical company, today announced that it has completed the acquisition of Oculeve, a development-stage medical device company.

Lately, I have been struggling to find time for the things I enjoy.

Pharmacists can play pivotal roles in pain management, such as counseling patients on properly selecting and using analgesics.

CVS Caremark recently released its 2016 formulary with several notable exclusions.

The public fear of human immunodeficiency virus has diminished since the 1980s crisis, and now many health care professionals are seeing less urgency surrounding HIV prevention and treatment.

Rupal Mansukhani, PharmD, clinical assistant professor at the Ernest Mario School of Pharmacy at Rutgers, talks about roadblocks to increasing immunization rates.

This episode of the Pharmacy Podcast Show features Timothy Aungst, PharmD, on mobile health, drones, and pharmacy technologies.

Infectious diseases pharmacotherapy is a challenging subject.

Learning how to cooperate with a manager should be every employee's goal.

Over the past decade we have seen a significant rise in opiate use and abuse, unfortunately, we have seen a paralleled rise in babies born addicted to opiates.

AstraZeneca today announced that MedImmune has entered into a license agreement and collaboration with Inovio Pharmaceuticals, a biotechnology company developing DNA-based immunotherapies.

AkzoNobel has won a coveted Red Dot Award for the digital version of its 2014 annual report.

In recognition of the third anniversary of EpiPen4Schools, Mylan, the marketer and distributor of EpiPen® Auto-Injector, has announced the program will continue through the 2015/2016 school year.

Shire today launches the second annual Excellence in ADHD Patient Group Awards celebrating outstanding work by patient advocacy organisations that aim to improve the lives of people with ADHD.

CVS Health Research Institute experts have encouraged the cardiology community to review and reconsider current treatment guidelines for the management of high cholesterol.

The FDA is alerting health care professionals about serious adverse effects reported with implantable left ventricular assist devices (LVADs).

Hospitals with higher admission rates for chest pain have lower rates of acute myocardial infarction (AMI) and death.

Cindy Lu, who is beginning her fourth year in the Doctor of Pharmacy program at Manchester University, was 1 of only 8 pharmacy students in the nation chosen as a Paul Ambrose Scholar.

Mylan has launched a generic version of AstraZeneca's proton pump inhibitor (PPI) Nexium.

School vaccination requirements have traditionally helped boost immunization rates, but in most states, parents may seek exemptions for religious, medical, or philosophical reasons.

Pharmacists have many opportunities for collaborating with nurse practitioners and physician assistants on managing chronic and acute conditions commonly seen in the retail health practice setting.

Michael Evans, Geisinger Health System, Receives Top Honor in Pharmacy; Industry Leaders Recognized at Sixth Annual Next-Generation Pharmacist Awards Gala

Pharmacy Times and Parata Systems honored pharmacists at the 2015 Next-Generation Pharmacist® Awards gala at Universal Studios in Orlando, Florida, on August 6.

Heart Hospital of New Mexico at Lovelace Medical Center has received the American Heart Association's Mission: Lifeline Heart Attack Receiving Center Accreditation.

University of California, San Francisco, (UCSF) pharmacy students are being trained to recognize and address unconscious bias in the pharmacy.

This weekly video program highlights the latest in pharmacy news, product news, and more.

Respiratory diseases affect millions worldwide and greatly burden the global health care system financially.

AstraZeneca and Heptares Therapeutics announced that they have entered a licensing agreement which AstraZeneca will acquire exclusive rights to develop the adenosine A2A receptor antagonist, HTL-1071.

Orexigen Therapeutics, Inc. and Takeda Pharmaceutical Company Limited today announced execution of an amended and restated collaboration agreement that resolves all outstanding disputes.